Torrent acquires a derma company. Speed jumps ranks in the category.

Torrent Pharmaceuticals (TP) has entered into definitive agreements to acquire 100% stake in Curatio Health Care (I) Private Limited (“Curatio”), a Chennai based dermatology company with a strong focus on cosmetic dermatology. Curatio was founded in 2005 and is backed by Sequoia, Anicut and ChrysCapital. It has a strong presence in the cosmetic dermatology segment … Read more

‘Dolo tablet makers doled out Rs 1,000 crore in freebies to doctors,’ SC told

Makers of popular paracetamol tablet Dolo-650 have distributed freebies worth about Rs 1,000 crore to doctors as consideration for prescribing the tablet, it has been alleged. Senior advocate Sanjay Parikh, representing an NGO Federation of Medical Sales Representatives Association of India, told the Supreme Court that the Central Board for Direct Taxes (CBDT) has made … Read more

Cipla to invest Rs 26 cr in digital tech co GoApptiv to raise stake to 22%

Pharma company Cipla has agreed to acquire an additional stake for nearly Rs 26 crore in digital tech company GoApptiv Private to raise its shareholding to 22.02 per cent, the company said on Monday. The investment will be made in equity shares and Compulsorily Convertible Preference Shares and is likely to be completed within 30 … Read more

Pharma packaging industry urged to develop elder friendly, child safety solutions

The Indian pharma packaging industry has been urged to come up with effective solutions towards child safety and elder friendly packaging of pharmaceutical products to safeguard their interest and to aid the growth of the pharma industry. “Pharma packaging is one of the important stakeholders of pharma industry,” said H. G. Koshia, Commissioner, Food & … Read more

The Indian patent regime and its clash with the U.S. norms

The U.S. Trade Representative highlighted IP challenges in India in its annual Special 301 report released last month The story so far: The U.S. Trade Representative (USTR) said in a report released last month that India was one of the most challenging major economies as far as IP protection and enforcement is concerned. It has … Read more

Biocon’s arm to acquire Viatris’ Biosimilars Assets for up to $3.33 billion

Biopharmaceutical company Biocon on Monday announced that the board of directors of Biocon Biologics Limited, a material subsidiary of Biocon Limited, has approved the proposed acquisition of biosimilars assets of Viatris Inc. The transaction is subject to necessary regulatory and other approvals. Viatris will receive consideration of up to $3.335 billion, including cash up to … Read more

Pharma industry likely to grow to $130 billion by 2030: Industry leaders

The pharmaceutical sector in the country can grow to USD 130 billion by 2030, industry captains said on Friday. He, along with other industry leaders, participated in a ‘CEOs Conclave’ as part of ‘BioAsia 2022’, the Telangana government’s flagship annual life sciences convention that concluded on Friday. “I think USD 130 billion by 2030 is … Read more

Ajanta Pharma decides to buyback again

The Company’s board is scheduled to meet on December 28, 2021 to take the decision. Key points to note – This is 3rd year in a row. Previous ones being Jan-Mar 2019 and Nov-Dec 2020. Jan – Mar 2019: Rs 100 crore at Rs 1,300 per share as against the then prevailing price of around … Read more